Navigation Links
Entry of Biogenerics and Decreasing Use of Amgen's Epogen and Johnson & Johnson's Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
Date:10/29/2007

Upheaval is Forecasted for the Markets of Five Chemotherapy Side Effect

Indications, According to a New Report from Decision Resources

WALTHAM, Mass., Oct. 29 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the drug market for chemotherapy-induced anemia will decline by $2.8 billion over the next decade owing to the entry of several biogeneric products and decreasing use of erythropoiesis-stimulating proteins, including Amgen's Epogen and Johnson & Johnson's Procrit.

The new Pharmacor report entitled Managing the Side Effects of Chemotherapy finds that biogeneric erosion combined with emerging safety concerns and an increasingly restrictive reimbursement landscape for erythropoiesis-stimulating proteins will cause the chemotherapy-induced anemia market to decline from $4.5 billion in 2006 to $1.7 billion in 2016. The report also finds that the chemotherapy-induced neutropenia market will decrease $1 billion by 2016 because of the entry of biogeneric versions of Amgen's Neupogen in 2008 in Europe and in 2013 in the United States.

Sales for the most common side effects of chemotherapy-anemia, neutropenia, thrombocytopenia, chemotherapy-induced nausea and vomiting, and oral mucositis-totaled more than $8 billion in 2006 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. According to the report, the market is dominated by therapies that manage anemia and neutropenia effectively for most patients, but considerable opportunity remains for drugs that address thrombocytopenia and oral mucositis, indications characterized by a lack of effective therapies.

"There will be upheaval in the markets for all five of the indications we looked at," said Ramya Kollipara, Ph.D., analyst at Decision Resources. "The decline in drug-treatment rates and the introduction of biogenerics will substantially constrain the market for anemia therapies through 2016, causing the value of the market to fall by nearly a third. Biogeneric erosion will also have a significant impact on the market for neutropenia therapies, and the introduction of novel emerging therapies will have a dramatic impact on the market for anti-thrombocytopenia agents as well."

The chemotherapy-induced nausea and vomiting market will see patent expiries of multiple agents that are thoroughly ingrained in physician treatment algorithms. For oral mucositis, the only available agent, Amgen's Kepivance, is approved only for the prevention of oral mucositis in patients receiving stem cell transplants, but increasing treatment rates and the launch of the first therapy for solid tumor patients will transform the oral mucositis market over the next ten years.

About Decision Resources

Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Sentry Insurance to add 30 IT jobs in Fox Valley
2. Fiserv plans single entry point for loan processing online
3. Johnson Controls deals for asset-tracking software
4. Johnson Controls adds renewable energy unit
5. Johnson Controls unit lands contract for plug-in hybrid battery
6. Johnson Controls to expand in Europe
7. Johnson Controls partners on car satellite linkup
8. Florida schools employ Johnson Controls technology to stop sex predators
9. Johnson Controls partnership wins new contract
10. Johnson Controls appoints Roell to head EOC
11. Johnson Controls reports record quarterly sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... Chef Jodi Abel has returned from her three-week tour through ... gained a number of delicious recipes and new techniques to share with her Lajollacooks4u ... Cape province. It is internationally renowned for its incredible wine farms, beautiful environment, ...
(Date:2/24/2017)... 2017  Aethlon Medical, Inc. (Nasdaq: AEMD ... Chairman and CEO, Jim Joyce . ... last Saturday, Bill Gates warned world leaders ... than nuclear weapons. Mr. Gates expressed his concern, which ... that scientific terrorists have access to the necessary tools ...
(Date:2/24/2017)... 2017  Driven by consumers, preference towards more ... fastest growing categories, finds the recently published U.S. ... Care: Multi-regional Market Analysis and Opportunities study ... Kline. "Biotechnology actives are derived from ... effective for skin and hair care applications," explains ...
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive small business that ... the goal of bringing their powerful cuvette and spectrophotometer calibration to the ... FireflySci is going on as they add yet another mark on the global map. ...
Breaking Biology Technology:
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
(Date:1/24/2017)... YORK , Jan. 24, 2017 ... study of the laboratory use of nuclear magnetic ... 363 experienced end-users and profiled current practices, developments, ... years, as well as growth and opportunities. These ... Instrument suppliers, NMR instruments, needs and innovation requirements, ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... offering. ... global voice recognition biometrics market to grow at a CAGR of ... the present scenario and the growth prospects of the global voice ... report considers the revenue generated from the sales of voice recognition ...
Breaking Biology News(10 mins):